Noppel Astrid

Singleron Biotechnologies is an innovative molecular diagnostic company dedicated to applying groundbreaking high-throughput single cell analyses to clinical research, diagnostics and drug development. 500+ single-cell sequencing experts around the world are working together to translate advanced and proprietary multi-omics single-cell technologies into products that can be easily deployed in any lab and provide improved research results faster than ever before. The company was incorporated in January 2018 and currently has offices and laboratories in China, US, and Germany. Contact: info@singleronbio.com